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Abstract 
Unsaturated fatty acids of odd carbons, 13:1(12), 17:l(10trans), 19:1(7) and 19:1(10) inhibited release of myeloperoxi- 
dase (MPO) from fMet-Leu-Phe-cytochalasin B-treated neutrophils. The inhibitory effect was smaller than that of 
aseanostatins which have been isolated as microbial-derived free fatty acids with a methyl blanch (i-14:0 and ai-15:0) 
(Journal of Antibiotics (1991) 44, 524-532). These unsaturated fatty acids also inhibited lactoferrin release by the same 
treatment. On the other hand, 13:1(12), 15:1(10) and 19:1(10) inhibited fMet-Leu-Phe-stimulated superoxide generation of 
neutrophils, and the fatty acids 15:1(10), 17:(10) and 19:2(10,13) induced superoxide generation i  both unstimulated cells 
and the cell-free system. However, none of unsaturated fatty acids of odd carbons tested inhibited /3-glucuronidase release, 
whereas 15:1(10), 17:1(10), 19:1(7), 19:1(10) and 19:2(10,13) rather enhanced an increase in /3-glucuronidase activity 
liberated from cells at high concentrations over 35 ~M, indicating cellular damages by these fatty acids. These observations 
suggest that unsaturated free fatty acids having odd carbons uch as 13, 15, 17 and 19 may act as modulators of neutrophil 
functions including degranulation and superoxide generation. 
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1. Introduction 
Neutrophils play an important roles in host defense 
by ingesting and destroying foreign cells and other 
infectious agents. Once ingestion occurs, hydrolytic 
and bactericidal enzymes such as myeloperoxidase 
(MPO), lysozyme or /3-glucuronidase (BGL) are re- 
leased from cytoplasmic granules into phagosome by 
the process of degranularion. Ingested material is also 
* Corresponding author. Fax: +81-3-5285-1160; e-mail: 
ksuzuki @ nih.go.jp 
vulnerable to attack by reactive oxygen metabolites 
produced by the phagosomal membrane. There have 
been reports of patients, who show a higher risk of 
various infections, with lack of granule formation, 
degranulation and superoxide generation [1-3]. 
However, these oxygen species and lysosomal en- 
zymes particitate in the bactericidal mechanisms of 
neutrophils, but also in the surrounding tissue injury 
caused by the disorder of neutrophil activation in a 
number of pathologies [4,5]. Moreover, anti-MPO 
antibodies have been sometimes detected in the sera 
of autoimmun disease patient as glomerulonephritis 
[6]. Modulation of neutrophil functions are necessary. 
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Then, it has been reported that some antibiotics [7,8], 
free fatty acids [9,10] or lipid metabolites released 
from stimulated neutrophils [11,12] modulate neu- 
trophil functions. In addition, we have previously 
demonstrated that aseanostatins (AS), free fatty acids 
of 14 and 15 carbons with a methyl branch, inhibit 
MPO release from activated neutrophils [13]. Thus, 
fatty acids are interesting in modulation of neutrophil 
functions. 
In the present study, we describe the effects of 
various free fatty acids, particularly unsaturated free 
fatty acids of odd carbons on neutrophil functions. 
We found that some unsaturated fatty acids showed 
inhibitory effects on release of MPO and lactoferrin 
(LF) from fMet-Leu-Phe-activated neutrophils. We 
also examined the effects on BGL release and super- 
oxide generation. 
2. Materials and methods 
2.1. Materials 
Saturated and unsaturated fatty acids of even car- 
bons from 4 to 22, C14:1(9), C16:1(9), C16:l(9trans), 
C18:1(9), C18:l(9trans), C18:2(9,12), C18:3(6,9,12), 
C18:3(9,12,15), C20:1(11), C22:1(13) and C24:1(15), 
were purchased from Gass-Chro Kogyo (Tokyo, 
Japan). Saturated fatty acids of odd carbons from 7 to 
23, authentic i-14:0 and ai-15:0 were purchased from 
Larodan Fine Chemicals (MalmS, Sweden). Unsatu- 
rated fatty acids of odd carbons, C13:1(12), 
C15:1(10), C17:1(10), C17:l(10trans), C19:1(7), 
C19:1(10), C19:2(10,13) and 20:5(5,8,11,14,17) so
called eicosapentaenoic acid (EPA), were purchased 
from Nu-Chek Prep (Elysian, MN, USA), 5-Hy- 
droxyeicosatetraenoic acid (5-HETE) and leukotriene 
B 4 (LTB 4) were from Cayman Chemical Co. (Ann 
Arbor, MI, USA). Lymphoprep was obtained from 
Nycomed Pharma As, (Oslo, Norway). Cytochalasin 
B (CB), 3,3', 5,5'-tetramethylbenzidine (TMB), cy- 
tochrome c, LF and O-phenylenediamine-di-hydro- 
chloride were purchased from Sigma Chemical (St. 
Louis, MO, USA). Formyl-methionyMeucyl-phenyl- 
alanine (fMet-Leu-Phe) was purchased from Peptide 
Institute Inc. (Osaka, Japan). Goat antiserum to hu- 
man LF, rabbit antiserum to human LF and peroxi- 
dase-labeled goat anti-rabbit IgG were purchased from 
Cosmo-Bio (Tokyo, Japan). Superoxide dismutase 
(SOD) was purchased from ICN Immunobiologicals 
(Costa Mesa, CA, USA). 
2.2. Preparation of human neutrophils 
Human neutrophils were prepared as described 
previously [14]. Briefly, neutrophils were obtained 
from peripheral heparinized blood (20 IU/ml  blood) 
of healthy adult volunteers using Lymphoprep and 
dextran methods. Neutrophils were suspended in 
Hanks' balanced salt solution (HBSS) at 2 X 10 6 
cells/ml. 
2.3. Preparation of fatty acid suspension 
Since fatty acids are usually insoluble in water, 
they were dissolved in methanol or dimethyl sulfox- 
ide (DMSO) to provide stock solutions at concentra- 
tion from 2 to 10 mg/ml.  They were diluted with 
phosphate-buffered saline without Ca 2÷ and Mg 2+ 
(PBS(-))  before use to give final concentrations of 
solvents below 1%. 5-HETE and LTB 4 were pro- 
vided as ethanol solutions. The suspensions of fatty 
acids were sonicated for a few minutes if needed. 
2.4. Release of lysosomal enzymes from neutrophils 
Prewarmed neutrophils (2 X 10 6 cells/ml for 10 
min at 37°C, 37.5 /zl) were exposed to solutions of 
fatty acids (7.5/zl), CB (final concentration 5/zg/ml)  
and fMet-Leu-Phe (final concentration 10 -6 M) in a 
96 well-V-plate (Nunc) for 10 min at 37°C in a total 
volume 75 /xl. After incubation, the plate was im- 
mersed into ice and centrifuged at 350 × g for 5 min 
at 4°C to separate supernatant from cell. The cell 
pellet was mixed with 150 /zl of 0.1% Triton X-100 
in HBSS. 
2.5. Measurement of MPO activity 
MPO activity was assayed as described previously 
[15]. Increase in absorbance at650 nm in the reaction 
mixture at 37°C was measured with an automatic 
analyzer LFA-096 (Japan Spectroscopic Co., Tokyo, 
Japan) at 30 s intervals. One unit was defined as the 
activity producing an increase of 0.001 in absorbance 
at 650 nm/min per ml of original MPO preparation. 
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2.6. Determination ofLF proteins 
LF protein in supernatant and cell homogenate was 
measured by ELISA method [16]. Briefly, a 100 /xl 
of 0.05% goat antiserum to human LF antibody 
diluted with reagent dilution buffer, 0.1% BSA in 
PBS(-  ) (pH7.4), was transferred toa 96 well-F-plate 
overnight at 4°C. After the plate was washed three 
times with PBS( - )  containing 0.05% Tween-20 
washing buffer, 100/xl of diluted supernatant or cell 
homogenate was added to the plate. After kept for 30 
min at room temperature, the plate was washed with 
the washing buffer three times, then a 100 /xl of 
0.1% rabbit antiserum to human LF was added to the 
plate. After kept for 30 rain at room temperature, the 
plate was washed three times with the washing buffer, 
and treated with a 100 /xl of 0.025% peroxidase- 
labeled goat anti-rabbit Ig G. The plate was kept for 
30 min at room temperature, washed three times with 
the washing buffer, and treated with a 200 /xl of 
enzyme substrate in 0.0.5 M citrate buffer (pH 5.0) 
containing 0.025% hydrogen peroxide and 0.04% of 
O-phenylenediamine-di-hydrochloride f  about 20 
min at room temperature', in the dark. Then, a 50 /zl 
of 2.5 N sulfuric acid was added to the plate to 
terminate the reaction, subsequently absorbance at 
490 nm was measured with an automatic analyzer 
LFA-096, and LF content in supernatant or cell ho- 
mogenate was determined. 
umbelliferone/min per ml of the original BGL 
preparation. 
2.8. Measurement of lactate dehydrogenase (LDH) 
Measurement of LDH was performed by a modi- 
fied method previously described [18]. Briefly, the 
reaction mixture consisted of 0.2 M Tris-hydrochro- 
ride (pH 7.3), 8 /xl of 6.6 mM NADH and 30 mM 
sodium pyruvate in a total volume of 230 /xl was 
allowed for 30-60 s in a tube at 25°C. Subsequently, 
a 10 /.d of neutrophil supernatant or cell homogenate 
was added. Then transferred the contents of the tube 
to a cuvette and absorption decrease/min at340 nm 
was measured at 25°C. 
2.9. Superoxide generation 
2.9.1. Intact cell assay 
Neutrophil suspension (2 × 10 6 cells/ml, 100 /_tl) 
and 66 /xM of cytochrome c were mixed in a 96 
well-F-plate and kept for approximately 2 rain. Then, 
solutions of fatty acid, CB (final concentration 5 
/xg/ml) and fMet-Leu-Phe (final concentration 10 -6 
M), were added to the suspension and the mixture 
was stood for 60 s at 37°C. The superoxide genera- 
tion was determined by measuring the increase in 
absorbance at 550 nm at 0.269 min intervals using 
the automatic analyzer LFA-096. 
2. Z Measurement ofBGL actiuity 
BGL activity in supernatant and cell homogenate 
was assayed by a modified method of previously 
described [17]. Briefly, the reaction mixture consisted 
of neutrophil supernatant or cell homogenate, 1 mM 
4-methylumbelliferyl-/3-D-glucuronide, 0.05% Tri- 
tonX-100 and 0.1 M sodium acetate buffer (pH 3.5) 
in a total volume of a 40 /xl in a 96 well-F-plate was 
incubated for 30 min at 37°C. A termination buffer 
(50 mM sodium glycine buffer (pH 10.4) containing 
5 mM EDTA-disodium) was added. Fluorescence 
intensity was measured by an automatic fluorescence 
analyzer LFA-96F (Japan Spectroscopic Co., Tokyo, 
Japan) with wavelengths at365 nm for excitation and 
405 nm for emission. One unit of BGL activity was 
defined as the activity liberating 1 pmol of 4-methyl- 
2.9.2. Cell-free assay 
Superoxide generation in a cell-free system was 
measured by the following method [19]. Membrane 
and cytosol fractions of neutrophils were prepared by 
centrifugation after nitrogen cavitation [20]. They 
were stored at -80°C until use. The cell-free assay 
was performed in a 96-well microtiter plates with a 
final volume of 100 Ixl/well. The reaction mixture 
contained fatty acid, the cytosol and solubilized 
membrane fractions, equivalent to 10 6 cells, 200/xM 
acetylated ferricytochrome c, 1 mM of EGTA, 1 mM 
magnesium chloride, 10 /xM GTP-'yS, 200 /xM 
NADPH, 100 /xM sodium dodecylsulfate (SDS) and 
10 mM Hepes buffer, pH 7.0. SOD of 125 U was 
added to the reaction mixture for the control. The 
reaction was started by addition of SDS. The maxi- 
mal linear rate of superoxide generation was deter- 
mined as that of SOD-inhibitable reduction of acety- 
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lated cytochrome c by measuring absorption at 550 
nm using a microplate reader (Bio-Rad Model 3550) 
with the program of Kinetic Collector 2.0. 
3. Results 
3.1. Effects of various saturated and unsaturated 
fatty acids on release of MPO from neutrophils 
We examined effects of various fatty acids on the 
release of MPO from neutrophils. All saturated and 
unsaturated fatty acids of even carbons slightly inhib- 
ited the release of MPO from neutrophils with half 
Table 1 
Effect of free fatty acids and aseanostatins AS on the release of 
MPO from fMet-Leu-Phe-treated neutrophils 
Saturated fatty acids 
Even carbons IC5o(/xM) Odd carbons IC5o(p~M) 
C4 874.0 C7 545.3 
C6 473.3 C9 331.9 
C8 > 1000 CI 1 87.5 
C10 423.7 C13 133.0 
C12 119.8 C15 280.8 
C14 394.0 C17 619.5 
C16 > 1000 C19 > 1000 
C18 > 1000 C21 > 1000 
C20 > 1000 C23 > 1000 
C22 > 1000 
Unsaturated fatty acids 
Even carbons IC5o(/xM) Odd carbons IC50(/zM) 
C14:1(9) 189.9 
C16:1(9) > 1000 
C16:l(9trans) > 1000 
C18:1(9) > 1000 
C18:l(9trans) > 1000 
C18:2(9,12) 260.2 
C18:3(6,9,12) > 1000 
C18:3(9,12,15) 222.6 
C20:1(11) > 1000 
C20:4(LTB,) > 300 
C20:4(5-HETE) > 300 
C20:5(EPA) > 1000 
C22:l(13) > 1000 
C24:1(15) > 1000 
AS 
IC 50(/xM) 
C13:1(12) 33.1 
C15:1(10) > 1000 
C17:1(10) > 1000 
C17: l(10trans) 149.0 
C19:1(7) 32.7 
C19:1(10) 11.1 
C19:2(10,13) > 1000 
AS i-14:0 7.5 
AS ai-15:0 4.5 
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Fig. 1. Effect of fatty acids of odd carbons on MPO release. 
Prewarmed neutrophils were treated with a solution of 13:1(12)- 
O-, 17:l(10t)-zx-, 19:1(7)-D- and 19:1(10)-O- at the indicated 
concentrations, or a mixture of CB and fMet-Leu-Phe as a 
control. See Section 2 in detail. 
inhibitory concentrations (IC5o) of over 100 /.~M 
(Table 1). LTB 4 and 5-HETE showed no inhibition 
even at more than 300 /xM. However, unsaturated 
fatty acids of odd carbons, C13:1(12), C19:1(7) and 
C19:1(10) showed relative greater inhibitions of re- 
lease of MPO with ICso values of less than 100/xM 
(Table 1), and 19:1(10) showed the strongest inhibi- 
tion, although the inhibitory effects of 19:1(10) and 
19:1(7) were reversed when the cells were treated 
with these at higher concentrations (Fig. 1). None of 
these unsaturated fatty acids of odd carbons inhibited 
MPO activity itself (data not shown). 
3.2. Effects of unsaturated fatty acids of odd carbons 
o17 release of LF 
Next we examined the effects of unsaturated fatty 
acids of odd carbons on the release of other lysoso- 
mal protein LF in the specific granule of neutrophils. 
The fatty acids 19:1(10) showed the strongest inhibi- 
tion of LF release in a dose-dependent manner among 
the fatty acids including 13:1(12), 15:1(10) and 
19:1(7) (Fig. 2). 
3.3. Effects of unsaturated fatty acids of odd carbons 
on superoxide generation in intact neutrophils and 
the cell-free extract 
We next examined the effects of unsaturated fatty 
acids of odd carbons on superoxide generation of 
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Fig. 2. Effect of fatty acids of odd carbons on LF release. 
Prewarmed neutrophils were treated with a solution of 13:1(12)- 
O-, 15:l(10)-A-, 19:1(7)-[3-and 19:1(10)-O- at the indicated 
concentrations, or a mixture of CB and fMet-Leu-Phe as a 
control. See Section 2 in detail. 
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Fig. 4. Activation of superoxide generation i  neutrophils by fatty 
acids of odd carbons. Prewarmed neutrophils were treated with a 
solution of 15:1(10)-O-, 17:l(10)-z~-, 19:2(10,13)-tq- and ai- 
15:0-O- at the indicated concentrations, or a mixture of CB and 
fMet-Leu-Phe as a control -• - .  See Section 2 in detail. 
neutrophils treated with fMet-Leu-Phe-CB. The fatty 
acids, 13:1(12), 15:1(10) and 19:1(10) showed in- 
hibitory effects on superoxide generation (IC50 values 
in a range of 10 to 30 /xM) (Fig. 3). On the other 
hand, 15:1(10), as well as 17:1(10), 19:2(10,13) and 
AS ai-15:0, induced superoxide generation i unstim- 
ulated neutrophils at higher concentrations more than 
40 tzM (Fig. 4). These effects of fatty acids were 
canceled by the addition of SOD, and also they did 
not reduce directly cytochrome c (data not shown). 
Increased levels of superoxide generation in fatty 
acid-treated neutrophils were almost similar to the 
levels of superoxide generation in fMet-Leu-Phe- 
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Fig. 3. Effect of fatty acids of odd carbons on superoxide 
generation. Prewarmed neutrophils were treated with a solution 
of 13:1(12)-O-, 15:l(10)-zx- and 19:1(10)-13- at the indicated 
concentrations, or a mixture of CB and fMet-Leu-Phe as a 
control. See Section 2 in detail. 
CB-treated cells. Since activated neutrophils produce 
superoxide anion by a series of enzymes localized in 
the membrane and cytoplasm, we examined the ef- 
fects of the fatty acids 15:1(10), 17:1(10), 19:2(10,13) 
and AS ai-15:0, in a cell-free superoxide generation 
system. They induced superoxide generation at con- 
centrations ranging from 30 to 250/xM (Fig. 5). The 
SOD-inhibitable superoxide generation was not in- 
duced by AS i-14:0 treatment in both unstimulated 
intact cells and the cell-free system (data not shown). 
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Fig. 5. Effect of fatty acids of odd carbons on superoxide 
generation in a cell-free system. The reaction mixture contained 
solution of 15:1(10)-O-, 17:l(10)-A-, 19:2(10,13)- []- and ai- 
15:0 -0 -  at the indicated concentrations. The reaction was started 
by adding of SDS -• -  as a control without adding of any fatty 
acids. See Section 2 in detail. 
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Fig. 6. Effect of fatty acids of odd carbons on BGL release from 
neutrophils. Prewarmed neutrophils were treated with solution of 
15:1(10)-C)-, 17:l(10)-A-, 19:1(7)-I11]-, 19:1(10)-O- and 
19:2(10,13)-zx- at the indicated concentrations. See Section 2 in 
detail. 
3.4. Effects of unsaturated fatty acids of odd carbons 
on release of BGL 
We also examined the effects of unsaturated fatty 
acids of odd carbons on BGL release from neu- 
trophils. Any of these fatty acids hardly did not 
inhibit BGL release from stimulated neutrophils. 
Among them, the fatty acids 15:1(10), 17:1(10), 
19:1(7), 19:1(10) and 19:2(10,13) rather increased 
BGL liberation from the cells at the concentrations 
more than 35/xM (Fig. 6). All these unsaturated fatty 
acids induced LDH leakage from neutrophils at these 
concentrations (Data not shown). The results indicate 
that the increase in BGL activity outside of neu- 
trophils was a secondary effect due to the cellular 
damages by these unsaturated fatty acids. 
4. Discussion 
We have isolated the fatty acids AS (i-14:0 and 
ai-15:0) as microbial products, which might regulate 
excess or abnormal release of MPO from human 
neutrophils [13]. In the present study, we further 
studied the effect of various free fatty acids on MPO 
release from human neutrophils. Among saturated 
and unsaturated fatty acids of even or odd carbons 
tested, unsaturated fatty acids of odd carbons uch as 
13:1(12), 17:1(100, 19:1(7) and 19:1(10) only showed 
inhibitory effects on MPO release, although their 
inhibition was weaker than that of AS. These fatty 
acids did not influence MPO activity. Cefdinir, a 
/3-1actam cephem antibiotic, inhibits the activity of 
human neutrophil MPO in the extracellular medium 
but not in the phagolysosomes [7]. Based on our 
findings in the present study, unsaturated fatty acids 
of odd carbons may be able to regulate an excess 
release of MPO from human neutrophils. For the 
release of another lysosomal protein LF which is 
contained in the specific granules, 13:1 (12), 15:1 (10) 
19:1(7) and 19:1(10) also showed the inhibition in a 
dose-dependent manner. Especially, 19:1(10) and AS 
are potent inhibitors of MPO and LF releases. 
We demonstrated here that unsaturated fatty acids 
of odd carbons, 13:1(12), 15:1(10), 19:1(10)and AS 
inhibited fMet-Leu-Phe-induced superoxide genera- 
tion of neutrophils. 19:1(10) also showed strong inhi- 
bition of superoxide generation adding to MPO and 
LF release. On the other hand, 15:1(10), 17:1(10), 
19:2(10,13) and ai-15:0 induced superoxide genera- 
tion in the cell-free system as well as unactivated 
neutrophils, uggesting that these fatty acids activated 
NADPH oxidase. It has been already reported fatty 
acids including arachidonicnate also activated 
NADPH oxidase to produce superoxide [10,21]. 
15:1 (10) and ai- 15:0 inhibited fMet-Leu-Phe-induced 
superoxide generation atthe concentrations more than 
4.4 and 3.6 /zM, respectively. On the other hand, 
these fatty acids induced superoxide at the higher 
concentrations more than 104 and 16.5 /zM, respec- 
tively, indicating the different concentrations for the 
inhibition and induction. Recently, it has been re- 
ported that exogenously-added arachidonic acid stim- 
ulated release of superoxide generation and lysoso- 
mal enzyme, but this required amounts of arachidonic 
acid which approximated the critical micellar concen- 
tration (over the concentration of 50 /zM) [11]. On 
the other hand, exogenously-added PLA 2 generated 
large quantities of free arachidonic acid in control 
and fMet-Leu-Phe-treated c lls (approx. 500 and 2000 
pmol/107 cells, respectively); however, this did not 
induce superoxide generation, or did it augment the 
level of superoxide stimulated by fMet-Leu-Phe [ 11 ]. 
Moreover, in spite of their structural similarity be- 
tween AS i-14:0 and AS ai-15:0, only ai-15:0 did 
induce superoxide generation but i-14:0 did not. The 
data suggest hat the slight differences in carbon 
chain length and position of methyl residue are criti- 
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cal for induction of superoxide generation. The induc- 
tion of superoxide generation by free fatty acids of 
even carbons in intact and cell-free preparations of 
neutrophils was reported [9,10]. It has been also 
reported that docosahexaenoic acid (DHA), 22:6 (n-3) 
increased the oxygen-dependent respiratory burst in- 
duced by fMet-Leu-Phe and TPA (phorbol 12-myri- 
state 13-acetate) in intact neutrophils in a dose depen- 
dent manner as measured by either SOD-inhibitable 
cytochrome c reduction and lucigenin-dependent 
chemiluminescence [22]. However, this stimulation of 
fMet-Leu-Phe-induced chemiluminescence was 
markedly inhibited by CB-pretreatment, but not in- 
hibited in TPA-induced cells. These data suggest that 
effects of various fatty .acids on superoxide genera- 
tion varies depending on different stimuli. It has been 
also reported that the activation of neutrophil 
NADPH-oxidase by free: fatty acids requires an ion- 
ized carboxyl group and their partitioning into mem- 
brane lipid [23]. We have also reported that the free 
carboxyl residue in AS is essential for also inhibition 
of MPO release [13]. 
The increases of BGL activity outside of neu- 
trophils by fatty acids of odd carbons at concentra- 
tions over 35 /xM was 1Ehought to be due to cellular 
damages, ince they induced LDH leakage from neu- 
trophils at the same concentrations. Free fatty acids 
are intrinsically cytotoxic to cells [24]. The antibi- 
otics, dirithromycin, erythromycylamine and erythro- 
mycin, directly induced the release of three intragran- 
ular proteins, BGL, lysozyme and LF from unstimu- 
lated human neutrophil,; [8]. The macrolide-induced 
enzyme-release was detected under the long exposure 
(30 to 180 min) at concentrations 10 to 140 /xM 
without any LDH leakage. The observations demon- 
strate different effects on BGL release between fatty 
acids of odd carbons and macroride antibiotics. 
Our data indicated that the fatty acids 19:1(10) 
inhibited MPO release dose-dependently, but hardly 
inhibited BGL release from neutrophil granules, sug- 
gesting that BGL is more mobile than MPO. It is not 
clear at present ime the reason for the different 
mobility between BGL and MPO. MPO and BGL 
exist in the same azurophil granules [25]. Henrik et 
al. compared mobilization of granules and secretory 
vesicles of human neutrophils, but it was not de- 
scribed differences of mobility between molecules 
belong to same granules uch as MPO and BGL [26]. 
We may conclude that some unsaturated fatty acids 
of odd carbons, especially 19:1(10), modulate various 
neutrophil functions, in which they inhibit MPO and 
LF release and superoxide generation. These fatty 
acids as well as AS i-14:0 might be useful for 
suppression of release of MPO, LF and superoxide 
generation from disorderly activated neutrophils. 
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